NCT02852148View on ClinicalTrials.gov

ACTICOAT™ for the Treatment of Burns and Chronic Wounds

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 28, 2017

Study Completion Date

December 13, 2017

Conditions
Wounds and InjuriesBurnsPressure UlcerFoot Ulcer
Interventions
DEVICE

ACTICOAT

ACTICOAT is a silver coated antimicrobial barrier dressing. ACTICOAT dressings consist of three layers: an absorbent inner core of polyester and rayon sandwiched between outer layers of silver coated, low adherent, high density polyethylene mesh.

Trial Locations (3)

NE630HP

Northumbria Healthcare NHS Foundation Trust, Ashington

LS12 3QE

Leeds Wounds Research Unit, Leeds

WF1 4EE

The Mid Yorkshire Hospitals NHS Trust, Wakefield

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT02852148 - ACTICOAT™ for the Treatment of Burns and Chronic Wounds | Biotech Hunter | Biotech Hunter